AbbVie (ABBV) Return on Invested Capital (2013 - 2026)

AbbVie (ABBV) has 14 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.0% in Q1 2026 per ABBV's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.22% in Q3 2025 and troughed at 0.0% in Q4 2023.
• A 5-year average of 0.02% and a median of 0.0% in 2026 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Return on Invested Capital changed 0 bps in 2022, then rose 21 bps in 2025.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then sank by 35 bps to 0.0% in 2023, then advanced by 26 bps to 0.0% in 2024, then increased by 18 bps to 0.0% in 2025, then advanced by 7 bps to 0.0% in 2026.
• Business Quant data shows ABBV's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.22% in Q3 2025.